Sign inJoin waitlistJoin the waitlist

Uzair Chaudhary

Chief of Medicine, UCSF Fresno · UCSF Fresno Medical Education Program

Credentials: · · · · · ·

History

UCSF Fresno Medical Education Program
Present
Hematology/Oncology Division · UCSF Fresno Medical Education Program
Present
Hematology/Oncology Division · UCSF Fresno
Present

Hematology and Medical Oncology
University of California-San Francisco
1995–1998
Internal Medicine
Indiana University Health University Hospital
1992–1995
Aga Khan University Medical College
1988–1992

Research

Long-term complications of chemotherapy for germ cell tumours
Review · Drugs · 2003 · First of 2 authors · Corresponding · 110 citations
Long-term experience with management of renal cell carcinoma involving the inferior vena cava
Urology · 2003 · Last of 8 authors · 105 citations
Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C₁₈-ceramide as a novel biomarker for monitoring response
Clinical Cancer Research · 2011 · 57 citations

NB
Nabil Bissada
8 papers
JL
John Lazarchick
5 papers
MR
Mohammad Rashid
5 papers
VG
Vinay Gudena
4 papers
Alberto Montero
3 papers · 1 as a resident
Andrew Kraft
3 papers
David Marshall
3 papers
JT
Jeffrey Turner
3 papers · 3 as a fellow
Keisuke Shirai
3 papers
Rishi Sawhney
3 papers · 3 as a fellow
TK
Thomas Keane
3 papers
Adedayo Onitilo
2 papers

Clinical trials

Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney Cancer
Principal investigator · Terminated · Phase 2
Medical University of South Carolina
2003–2009
Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Stomach Cancer
Study chair · Terminated · Phase 2
Medical University of South Carolina
2005–2008
PEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer
Study chair · Terminated · Phase 2
Medical University of South Carolina
2002–2010
Gemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder Cancer
Study chair · Terminated · Phase 2
Medical University of South Carolina
2001–2008